Institute of Medicine (U.S.). Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Institute of Medicine (U.S.). Board on Population Health and Public Health Practice, ebrary, Inc, & Wizemann, T. (2010). Public health effectiveness of the FDA 510(k) clearance process: Balancing patient safety and innovation : workshop report. National Academies Press.
Ondo kopiatu da
Kopiatzeak huts egin du
Chicago Style (17th ed.) Zitazioa
Institute of Medicine (U.S.). Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Institute of Medicine (U.S.). Board on Population Health and Public Health Practice, Inc ebrary, eta Theresa Wizemann. Public Health Effectiveness of the FDA 510(k) Clearance Process: Balancing Patient Safety and Innovation : Workshop Report. Washington, D.C.: National Academies Press, 2010.
Ondo kopiatu da
Kopiatzeak huts egin du
MLA (9th ed.) Zitazioa
Institute of Medicine (U.S.). Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, et al. Public Health Effectiveness of the FDA 510(k) Clearance Process: Balancing Patient Safety and Innovation : Workshop Report. National Academies Press, 2010.
Ondo kopiatu da
Kopiatzeak huts egin du
Kontuz: berrikusi erreferentzia hauek erabili aurretik.